BI-2865 IC50 for Cell-based and Cell-free Assays

Jump to:

• BI-2865 Mechanism of Action: KRAS Inhibition in Cancer Cell Research
• Selectivity & Specificity
• BI-2865 Working Concentration | Cell Culture | Treatment
• BI-2865 Solubility in DMSO
• BI-2865 Storage & Stability
• BI-2865 Combination Database
• BI-2865 Molecular Weight | Chemical Structure | Stock Solution
• BI-2865 Sigma (SML4151)? Try a better option.
• BI-2865 MCE (HY-153724)? Try a better option.
• BI-2865 Abmole (M40499)? Try a better option.
• BI-2865 TargetMol (T72061)? Try a better option.
• BI-2865 BPS Bioscience (82711-3)? Try a better option.
• BI-2865 SDS｜MSDS
• BI-2865 in Pan-KRAS Targeted Therapy for Solid Tumors
• BI-2865 in Multidrug Resistance Reversal
• BI-2865 in Combination Therapy and Acquired Resistance